Comparative Effectiveness and Personalized Medicine Research Using Real-World Data (Chapman & Hall/CRC Biostatistics Series) (PDF)

by Thomas P. A. Debray (ed.), Tri-Long Nguyen (ed.), Robert W. Platt (ed.)

Comparative effectiveness research has become essential for shaping regulatory policy, informing economic evaluations, and guiding treatment standardization across healthcare systems worldwide. While traditional randomized controlled trials remain the cornerstone of evidence generation, they have important limitations when treatment effects are heterogeneous. In practice, patients often respond differently to the same intervention due to differences in demographics, genetics, comorbidities, and other contextual factors. This variability creates challenges for personalized medicine and limits the generalizability of trial results to diverse real-world patient populations.
This comprehensive guide addresses these critical gaps by exploring how real-world data from electronic health records, patient registries, and observational studies can transform comparative effectiveness research and enable truly personalized treatment decisions. Comparative Effectiveness and Personalized Medicine Research Using Real-World Data provides detailed methodological frameworks for moving beyond traditional subgroup analyses to sophisticated approaches that harness the full potential of real-world evidence for individualized patient care.
Features

Comprehensive coverage of statistical techniques for analyzing heterogeneity of treatment effects and estimating individualized treatment effects
Innovative approaches for combining diverse data sources to generate robust comparative effectiveness evidence
Cutting-edge algorithms and computational methods for personalized medicine applications
Real-world examples, case studies, and vignettes demonstrating successful applications in clinical practice
Access to dedicated online training materials, example code, and supplementary content through companion websites
Current guidance from FDA, EMA, and other regulatory bodies on real-world evidence in decision-making

This text serves as an essential resource for healthcare researchers, biostatisticians, epidemiologists, health economists, regulatory professionals, and clinicians seeking to understand and implement advanced methodologies in comparative effectiveness research. Written through collaboration between leading experts in healthcare research, biostatistics, epidemiology, and health policy, it provides both theoretical foundations and practical tools for leveraging real-world data in evidence generation. The book is particularly valuable for professionals involved in regulatory submissions, health technology assessments, treatment guideline development, and personalized medicine initiatives, offering the methodological rigor needed to enhance the credibility and reliability of real-world evidence in healthcare decision-making.